Related Experiment Video
Updated: Jun 15, 2026

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
Published on: July 16, 2021
[Amyotrophic lateral sclerosis and frontotemporal dementia: overlapping characteristics]
Joost Raaphorst1, Hepke F Grupstra, Wim H J P Linssen
1Academisch Medisch Centrum/Universiteit van Amsterdam, Afd. Neurologie, Amsterdam, The Netherlands. j.raaphorst@amc.uva.nl
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share overlapping symptoms and genetic links. Research into ubiquitin inclusions and mutations in the PGRN and TARDBP genes offers insights into the pathogenesis of both neurodegenerative diseases.
Area of Science:
- Neuroscience
- Genetics
- Neurology
Background:
- Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) exhibit significant clinical overlap.
- Approximately 5-10% of ALS patients display FTD-like behavioral changes, and 10% of FTD patients develop ALS.
- Mild cognitive impairment affects up to 30% of ALS patients.
Purpose of the Study:
- To investigate the overlapping characteristics between ALS and FTD.
- To explore the potential genetic and pathological links between these neurodegenerative conditions.
- To provide insights into the pathogenesis of ALS and FTD.
Main Methods:
- Examination of ubiquitin-positive inclusions in the hippocampus and anterior horn cells of ALS and FTD patients.
- Genetic analysis for mutations in the progranulin (PGRN) gene in familial FTD.
- Identification of TAR-DNA-binding protein-43 (TARDBP) in ubiquitin inclusions.
Main Results:
- Ubiquitin-positive inclusions were observed in some ALS and FTD patients.
- Mutations in the PGRN gene were found in familial FTD patients with ubiquitin inclusions.
- TARDBP gene mutations, encoding TAR-DNA-binding protein-43, were identified in ALS patients.
Conclusions:
- The study highlights shared pathological features and genetic factors in ALS and FTD.
- Findings suggest a common pathway in the pathogenesis of these disorders.
- Further research into PGRN and TARDBP may elucidate disease mechanisms and potential therapeutic targets.
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease l: Introduction
Parkinson's Disease: Overview
Alzheimer Disease ll: Pathophysiology
Huntington Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

